The development of Spectrochip is based on Dr. Ko's major breakthrough in the research of spectral wafers in the past 17 years. Spectrochip has obtained a number of patents in the United States, China and Taiwan. Spectrochip has three modules of spectrum chip that has obtained TFDA certification. Spectrochip actively cooperated with domestic large hospitals and long-term care service center and conducts research on various IRB cases, which enables the accuracy of the instrument be verified by actual clinical data. Based on the data retrieved by the current IRB case, the spectrum chips from Spectrochip has matched the accuracy for almost above 99%.
Spectrochip InstantCare Chromogenic Reader can provide more sensitive and accurate analysis for COVID-19 IgG/IgM test strip. Objective evaluations make improvement of the limitation of naked eyes and decrease the probability of false negative results. Besides of its light weight, it is portable and for use at Point of Care (POC).
Copyright © 2023 Mes Med - All Rights Reserved.